Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × ruxolitinib × 30 days × Clear all

Sponsor

Conditions

Primary Myelofibrosis 5 Thrombocythemia, Essential 3 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Polycythemia Vera 2 Myelodysplastic-Myeloproliferative Diseases 2 Myelodysplastic Syndromes 2 Leukemia 2 Thalassemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Leukemia, Monocytic, Acute 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Graft vs Host Disease 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1 Bronchiolitis Obliterans Syndrome 1

Interventions

Vincristine 3 Cyclophosphamide 3 pegaspargase 2 merphos 2 asparaginase erwinia chrysanthemi recombinant 2 Spinal Puncture 2 Specimen Handling 2 Methotrexate 2 Leucovorin 2 Cytarabine 2 Asparaginase 2 venetoclax 1 prednylidene 1 fludarabine phosphate 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 calaspargase pegol 1 blinatumomab 1 azathiopurine 1 auricularum 1 X-Rays 1 Thioguanine 1 Radiotherapy 1 Radiation 1 Prednisone 1 Prednisolone 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Methylprednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡